Behavioral effects of ivermectin in mice

Laboratory Animal Science

Volumn 49, Issue 3, 1999, Pages 288-296

  Davis, Judith A ^a   Paylor, Richard ^b   McDonald, Michael P ^b   Libbey, Megan ^b   Ligler, Amy ^b   Bryant, Katherine ^b   Crawley, Jacqueline N ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; IMMOBILIZATION STRESS; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SENSORIMOTOR FUNCTION; SPATIAL MEMORY; SWIMMING; TASK PERFORMANCE;

ACOUSTIC STIMULATION; ANIMALS; ANTHELMINTICS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; FEMALE; IVERMECTIN; MALE; MICE; MICE, INBRED STRAINS; MITE INFESTATIONS; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; NEURAL INHIBITION;

EID: 0033019682     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Bennett, D. G. 1986. Clinical pharmacology of ivermectin. J. Am. Vet. Med. Assoc. 189:100-104.
2. Lankas, G. R., and L. R. Gordon. 1989. Acute toxicity of ivermectin, p. 89-112. In W. C. Bennett (ed.), Ivermectin and abamactin. Springer-Verlag, New York.
3. Summa, M. E. L., L. Ebisui, J. T. Osaka, et al. 1992. Efficacy of oral ivermectin against Trichosomoides crassicauda in naturally infected laboratory rats. Lab. Anim. Sci. 42: 620-622.
4. Ostlind, D. A., M. A. Nartowicz, and W. G. Mickle. 1985. Efficacy of ivermectin against Syphacia obvelata (Nematoda) in mice. J. Helmin. 59:257-261.
5. Klement, P., J. M. Augustine, K. H. Delaney, et al. 1996. An oral ivermectin regimen that eradicates pinworms (Syphacia spp.) in laboratory rats and mice. Lab. Anim. Sci. 46: 286-290.
6. Lipman, N. S., S. D. Dalton, A. R. Stuart, et al. 1994. Eradication of pinworms (Syphacia obvelata) from a large mouse breeding colony by combination of oral anthelmintic therapy. Lab. Anim. Sci. 44:517-520.
7. Huerkamp, M. J. 1993. Ivermectin eradication of pinworms from rats kept in ventilated cages. Lab. Anim. Sci. 43:86-90.
8. Flynn, B. M., P. A. Brown, J. M. Eckstein, et al. 1989. Treatment of Syphacia obvelata in mice using ivermectin. Lab. Anim. Sci. 39:461-463.
9. Kerrick, G. P., D. E. Hoskins, and D. H. Ringler. 1995. Eradication of pinworms from rats by using ivermectin in the drinking water. Contemp. Top. Lab. Anim. Sci. 34:78-97.
10. Taylor, D. M. 1992. Eradication of pinworms (Syphacia obvelata) from Syrian hamsters in quarantine. Lab. Anim. Sci. 42:413-414.
11. LeBlanc, S. A., R. E. Faith, and C. A. Montgomery. 1993. Use of topical ivermectin treatment for Syphacia obvelata in mice. Lab. Anim. Sci. 43:526-528.
12. Battles, A. H., S. W. Adams, C. H. Courtney, et al. 1987. Efficacy of ivermectin against natural infection of Syphacia muris in rats. Lab. Anim. Sci. 37:791-792.
13. Huerkamp, M. J. 1990. Letter to the editor. Lab. Anim. Sci. 40:5.
14. Burdett, E. C., R. A. Heckmann, and R. Ochoa. 1997. Evaluation of five treatment regimens and five diagnostic methods for murine mites (Myocoptes musculinus and Myobia musculi). Contemp. Top. Lab. Anim. Sci. 36:73-76.
15. Levee, E. M., M. M. Klinger, C. C. Kaiser, et al. 1994. A practical delivery method for oral administration of ivermectin to large colonies of rodents. Contemp. Top. Lab. Anim. Sci. 33:68-69.
16. Baumans, V., R. Havenaar, and H. Van Herck. 1988. The use of repeated treatment with Ivomec and Neguvon spray in the control of murine fur mites and oxyurid worms. Lab. Animals 22:246-249.
17. Mundell, A. C., and P. J. Ihrke. 1991. Ivermeetin in the treatment of Pneumonyssoides caninum: a case report. Canine Med. Fall/Winter:20-21.
18. Bowman, D. D., M. L. Fogelson, and L. G. Carbone. 1992. Effect of ivermectin on the control of ear mites (Psoroptes cuniculi) in naturally infested rabbits. Am. J. Vet. Res. 53:105-109.
19. McKellar, Q. A., D. M. Midgley, E. A. Galbraith, et al. 1992. Clinical and pharmacological properties of ivermectin in rabbits and guinea pigs. Vet. Rec. 130:71-73.
20. Hirsjarvi, P., and L. Phyala. 1995. Ivermectin treatment of a colony of guinea pigs infested with fur mite (Chirodiscoides caviae). Lab. Animals 29:200-203.
21. Sango, K., S. Yamanaka, A. Hoffmann, et al. 1995. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurological phenotype and ganglioside metabolism. Nat. Genet. 11:170-176.
22. Barlow, C., S. Hirotsune, R. Paylor, et al. 1996. Atm-deficient mice: a paradigm of Ataxia telangiectasia. Cell 86: 159-171.
23. Paylor, R., and J. N. Crawley. 1997. Inbred strain differences in prepulse inhibition of the mouse startle reflex. Psychopharmacology 132:169-180.
24. Lijam, N., R. Paylor, M. P. McDonald, et al. 1997. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 80:895-905.
25. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
26. DeFries, J. C., M. C. Gervais, and E. A. Thomas. 1978. Response to 30 generations of selection for open-field activity in laboratory mice. Behav. Genet. 8:3-13.
27. Crawley, J. N., J. K. Belknap, A. Collins, et al. 1997. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132:107-124.
28. Davis, M. 1970. Effects of interstimulus interval length and variability on startle response habituation in the rat. J. Comp. Physiol. Psych. 72:177-192.
29. Geyer, M. A., N. R. Swerdlow, R. S. Mansbach, et al. 1990. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 25:485-498.
30. Morris, R. G. M. 1981. Spatial localization does not depend on the presence of local cues. Learning Motivation 12:239-260.
31. Hooks, M. S., and P. W. Kalivas. 1995. The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation. Neuroscience 64:587-597.
32. Nafstad, J., E. Sannes, A. Hem, et al. 1991. Behavioral method to detect marginal neurotoxic effects of ivermectin in DA/Orl rats. J. Exp. Anim. Sci. 34:81-86.
33. Diggs, H. E., D. J. Feller, J. C. Crabbe, et al. 1990. Effect of chronic ivermectin treatment on GABA receptor function in ethanol withdrawal-seizure prone and resistant mice. Lab. Anim. Sci. 40:68-71.
34. Poul, J. M. 1988. Effects of perinatal ivermectin exposure on behavioral development of rats. Neurotoxicol. Teratol. 10: 267-272.
35. Schinkel, A. H., E. Wagenaar, C. A. A. M. Mol, et al. 1996. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97:2517-2524.
36. Schinkel, A. H., J. J. M. Smit, O. van Tellingen, et al. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
37. Umbenhauer, D. R., G. R. Lankas, T. R. Pipert, et al. 1997. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol. Appl. Pharmacol. 146:88-94.
38. Lankas, G. R., M. E. Cartwright, and D. Umbenhauer. 1997. P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol. Appl. Pharmacol. 143:357-365.
39. Skopets, B., R. P. Wilson, J. W. Griffith, et al. 1996. Ivermectin toxicity in young mice. Lab. Anim. Sci. 46: 111-112.
40. Poison Control Monograph - Ivermectin. Courtesy of Dr. John J. Melancon, Field Technical Services, Division of Merck & Co., Inc., 1986.
41. Risau, W., and H. Wolburg. 1990. Development of the blood-brain barrier. Trends Neurosci. 13:174-178.
42. Fischer, G. W., J. K. Podgore, and J. W. Bass. 1975. Enhanced host defense mechanisms with levamisole in sucking rats. J. Infect. Dis. 132:578-581.
43. Blakley, B. R., and C. G. Rousseaux. 1991. Effect of ivermectin on the immune response in mice. Am. J. Vet. Res. 52:593-595.
44. Cunliffe-Beamer, T. L., and D. D. Myers. Letter, October 1, 1997; subject: MP-24 Myocoptes musculinus free.
45. Lubcke, R., F. A. R. Hutcheson, and G. O. Barbezat. 1992. Impaired intestinal electrolyte transport in rats infested with the common parasite Syphacia muris. Dig. Dis. Sci. 37:60-64.
46. Coghlan, L. G., D. R. Lee, B. Psencik, et al. 1993. Practical and effective eradication of pinworms (Syphacia muris) in rats by use of fenbendazole. Lab. Anim. Sci. 43:481-487.
47. Hamlen, H. J., S. A. Kargas, and J. R. Blum. 1994. Ivermectin overdose in a group of laboratory mice. Contemp. Top. Lab. Anim. Sci. 33:49-51.
48. Jackson, T. A., G. P. Boivin, J. E. Hall, et al. 1997. Ivermectin toxicity in multiple transgenic mouse lines. Poster 067, National AALAS Meeting, Anaheim, Calif.
49. Zenner, L. 1998. Effective eradication of pinworms (Syphacia muris, Syphacia obvelata, Aspicularis tetraptera) from a rodent breeding colony by oral anthelmintic therapy. Lab. Animals 32:337-342.
50. Uhlir, J., and P. Volf. 1992. Ivermectin: its effect on the immune system of rabbits and rats infested with ectoparasites. Vet. Immunol. Immunopathol. 34:325-336.
51. Krause, R. M., B. Buisson, S. Bertrand, et al. 1998. Ivermectin: a positive allosteric effector of the a7 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53:283-294.